Presentations 2011

This website is part of the ECDC (European Centre for Disease Prevention and Control) network

View pda web

Font:
Accessibility

Home

About ESCAIDE

Travel & Accommodation

Presentations 2011

Presentations: Archive by year

Presentations: Archive by topic

Presentations 2011

Presentations from the ESCAIDE 2011 conference

Keynote plenary address

Control of infectious diseases in complex emergency situations, Dr. Marie-Pierre Allié

Plenary Session B - Parasitic infections of increasing relevance for Europe

Climate and global change effects on zoonotic parasitic diseases, Prof. Dr. Santiago Mas-Coma

Emergence of food-borne parasitic diseases, Prof. Dr. Pierre Dorny

Endemic parasitic diseases in Europe: recent trends in echinococcosis and other cestode infections, Dr. Thomas Romig

Present capacities and expertise on parasitic diseases in Europe, Prof. Dr. Jean Dupouy-Camet

Plenary Session C - The Hospital as an infectious disease amplifier

Gram-positive Bacteria, Dr. Alex W. Friedrich

The era of multiresistant Gram-negative infections: From genomics to prevention, Dr. Vivi Miriagou

The role of international surveillance, alert, networks and collaboration policy against HC-associated infections, Dr. Bruno Coignard

Parallel session 7 - Travel and mass gathering

Preparations for the London 2012 Olympics - Pilot Study of Enhanced Surveillance for Undiagnosed Serious Infectious Illness (USII), Ms. Ellen Heinsbroek

Public Health Surveillance during the 2012 Olympic and Paralympic Games, Ms. Ellen Heinsbroek

Risk of Travel-associated Legionnaires’ disease in Europe, Dr. Julien Beauté

Parallel session 8 - Influenza

Influenza vaccine effectiveness in Europe, 2010-11: estimates from the I-MOVE multicentre case-control study by age group, influenza subtype and among target groups for vaccination, Ms. Esther Kissling

Surveillance of Hospitalised Severe Cases of Influenza A(H1N1) 2009 and Related Fatalities during the 2009 Influenza Pandemic in Ten EU Countries, Dr. René Snacken

Parallel session 9 - International Health

Epidemiology of Cholera in Thailand, 2001-2010, Ms. Suchada Juntasiriyarkorn

Evaluation of Measles Case-Based Surveillance System – Nigeria, 2010, Dr. Abdulaziz Mohammed

Impact of the 2010-2011 cholera epidemic on disadvantaged areas of Cap Haïtien, North Haiti - a retrospective morbidity and mortality survey, Ms. Maud Ginsbourger

Non epidemic cholera cases: risk factors contributing to maintain transmission in Lusaka, Zambia, 2010-2011 cholera season, Dr. Grazia Marta Caleo

The impact of the cholera epidemic on the crude mortality rate in Haiti - a retrospective mortality survey in an urban setting, April 2011, Ms. Marie-Amélie Degail

Parallel session 10 - Migration and population movement

Assessment visit to the Greek-Turkish border: public health of migrants, April 2011, Dr. Elke Mertens

Tuberculosis case finding based on symptoms screening among irregular immigrants, refugees and asylum seekers in Rome, Dr. Monica Sane Schepisi

Unwanted souvenirs? Trends in Chlamydia incidence among Swedish travellers to different overseas destinations, Dr. Valerie Decraene

Uptake of health examinations among adult foreign-born TB patients in Stockholm, Sweden, 2011, Ms. Filipa Sampaio

Parallel session 11 - Vaccine uptake/coverage

A new model for vaccination coverage data collection from the European Union Member States: a proposal of the VENICE network, Dr. Fortunato D'Ancona

Exploring the decline in MenC3 and Hib booster vaccination uptake following the 2008 changes in vaccination schedule in Ireland, Ms. Javiera Rebolledo

HPV vaccination of girls and participation of their mothers in the cervical cancer screening programme in the Netherlands, Ms. Anneke Steens

Impact of immunization practices on the epidemiology of measles, in a village in the South of France, November 2010-January 2011, Ms. Laure Meurice

Whom and where are we not vaccinating? Combined use of cluster sampling and LQAS methodologies to guide future campaign strategies for multi- phased introduction of a new conjugate vaccine against group A meningococcus in Niger, 2010, Dr. Lorenzo Pezzoli

Parallel session 12 - Novel methodological approaches to outbreak investigation, risk assessment and communication

A new risk assessment tool for contact tracing after exposure to infectious diseases in public ground transport, Dr. Julia Hermes

Data-driven selection of the phylogenetically informative genomic region for linking outbreaks, Dr. Linda Verhoef

Diagnosticat: a disease surveillance system derived from electronic health record data, Mr. Leonardo Méndez Boo

FEMwiki - what promotional strategies enable an active online network of field epidemiologists?, Mr. Vladimir Prikazsky

Spatiotemporal analysis shows that infection clusters with sheer male dominance are rising incidence of Acute Hepatitis A (AHA) in Italy: a nationwide five-year analysis, Dr. Simone Lanini

Parallel session 13 - From outbreak investigation to policy changes

Evaluation of the impact of Salmonella control programmes in fowl (Gallus gallus) on public health in the EU, Mr. Frank Boelaert

Risk factors for delayed start of tuberculosis treatment in the South West Region of England, 2008-2010, Mrs. Alma Tostmann

An outbreak of severe respiratory tract infection caused by human metapneumovirus in a residential care facility for elderly, Dr. Margreet te Wierik

Gastroenteritis outbreak due to Salmonella Enteritidis following the consumption of wild boar meat in central France, Mr. Francisco Nogareda

Widespread mumps outbreak and effect of supplemental MMR vaccination in a rural district, Thailand, June–October 2010, Dr. Manita Phanawadee

Parallel session 15 - Vaccine effectiveness

Decline of serogroup C meningococcal disease in Portugal after introduction of conjugate meningococcal C vaccine 2002-2010, Mr. Erik de Jonge

Mumps complications and vaccine effectiveness during a mumps outbreak among mainly vaccinated students in the Netherlands, Mr. Ewout Fanoy

Trends in invasive pneumococcal disease in north-east England between 2006 and 2010 following the introduction of the pneumococcal conjugate vaccine, Dr. Kaye Chapman

Plenary Session D- Enhancing health and health equality through vaccination programmes

Economic and Societal Value of Vaccination, Professor Andrew Farlow

Economical evaluation in the decision making process regarding introduction of new vaccines in Europe, Dr. Daniel Levy-Bruhl

Social determinants impacting on vaccine uptake, Dr. Anette Siedler

Parallel session 16 - Zoonoses

Analysis of factors associated with Salmonella contamination of broiler carcasses, EU-wide baseline survey, 2008, Mr. Frank Boelaert

Large outbreak of Vero cytotoxin-producing Escherichia coli O157 infection in visitors to an open farm in South East England in 2009, Mr. Peter Kinross

Two consecutive Salmonella Enteritidis PT4 outbreaks in 2010 related to one laying hen holding: pitfalls of regulatory responses in risk management, Austria, Dr. Yu-Lun Liu

Parallel session 17 - Surveillance

HCV serosurvey in surgery and orthopedic wards to assess general population prevalence, Dr. Magdalena Rosińska

Postpandemic Sentinel Surveillance for Severe Acute Respiratory Infections, Romania, 2010-2011, Dr. Odette Nicolae

Sentinel surveillance network for rotavirus diarrhea in six NIS(Newly Independent States) in 2010, Dr. Annemarie Wasley

Parallel session 18 - Vacine safety and assessment

Abrupt increase in incidence of narcolepsy in children and adolescents, not in adults after pandemic vaccination in Finland in 2010, Dr. Hanna Nohynek

Molecular epidemiology of rotavirus strains in European Countries with or without rotavirus immunization programs, Dr. Miren Iturriza-Gomara

Trends in Meningococcal Disease in Spain following the introduction of the Meningococcal C conjugated Vaccine, Dr. Zaida Herrador

Vaccine safety of a new conjugate vaccine against group A meningococcus during the September 2010 mass vaccination campaign in Filingue, Niger, Dr. Maman Sani Chaibou

Parallel session 19 - Vaccine Preventable Diseases

High proportion of adults affected by community outbreak of measles in Berlin, Germany, May-June 2011, Ms. Sofie Gillesberg Lassen

Measles outbreak in France: still far from disease elimination!, Dr. Denise Antona

Pertussis in Europe from 1980-2010 – incidence and vaccination coverage, Mrs. Elisabeth Eva Kanitz

Poliomyelitis outbreak in young adults in Pointe-Noire, Republic of the Congo, 2010, Dr. Arnaud Le Menach

Parallel session 20 – Burden of disease

Measuring the burden of communicable diseases – linking disability weights and incidence data, Dr. Juanita Haagsma

Ranking the burden of infectious diseases: the Ontario Burden of Infectious Disease Study (ONBOIDS), Ms. Sujitha Ratnasingham

The burden of influenza: evaluation of the Disability Adjusted Life Years (DALYs) and hospital utilization in Italy, Mrs. Silvia Longhi

The pathogen- and incidence based DALY approach – a method to measure the burden of communicable diseases in Europe, Dr. Juanita Haagsma

Parallel session 21 – FWD surveillance & Method

Now-Casting during a huge outbreak of haemolytic–uremic syndrome in Germany, 2011, Dr. Matthias an der Heiden - Part 1

Now-Casting during a huge outbreak of haemolytic–uremic syndrome in Germany, 2011, Dr. Matthias an der Heiden - Part 2

Usefulness of a web-based questionnaire for quantification and investigation during a large waterborne cryptosporidiosis outbreak in Northern Sweden, April 2011, Dr. Stephan Stenmark

Special Plenary session: EHEC/HUS 2011

Challenges in unmasking a stealth vehicle in a large outbreak of haemolytic uraemic syndrome caused by STEC O104, associated with sprouts, Germany, 2011, Dr. Mona Askar

Danish Outbreak Investigation Related to a Large Outbreak of Shiga Toxin-producing E. coli O104 in Germany, May-June 2011 - The Important Role of Outlier, Mrs. Luise Müller

STEC O104: How emerging information supported policy decision and public health action, Gerard Krause

The key role of microbiological characterisation during the EHEC O104:H4 outbreak in Germany, Mrs. Camille Escadafal


European Centre for Disease Prevention and Control (ECDC) 2005 - 2012	Legal notice

Presentations 2011

Parallel session 1 - Antimicrobial resistance/Healthcare-associated infections

Parallel session 2 - Contribution of modeling to applied epidemiology

Parallel session 3 - Food- and water-borne diseases

Parallel session 4 - Outbreaks 1

Parallel session 5 - Vector Borne Disease

Parallel session 6 - HIV/STI

Parallel session 7 - Travel and mass gathering

Parallel session 8 - Influenza

Parallel session 9 - International Health

Parallel session 10 - Migration and population movement

Parallel session 11 - Vaccine uptake/coverage

Parallel session 12 - Novel methodological approaches to outbreak investigation, risk assessment and communication

Parallel session 13 - From outbreak investigation to policy changes

Parallel session 15 - Vaccine effectiveness

Parallel session 16 - Zoonoses

Parallel session 17 - Surveillance

Parallel session 18 - Vacine safety and assessment

Parallel session 19 - Vaccine Preventable Diseases

Parallel session 20 – Burden of disease

Parallel session 21 – FWD surveillance & Method